MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.53
-0.05 (-0.30%)
May 26, 2026, 2:43 PM EDT - Market open
MediWound Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, MediWound stock has a consensus rating of "Strong Buy" and an average price target of $31.33. The average 1-year stock price forecast is 89.53% higher than the current stock price, while the lowest is $25 (+51.24%) and the highest is $39 (+135.93%).
Price Target: $31.33 (+89.53%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for MediWound stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Dec '25 | Jan '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $25 | Buy | Maintains | $25 | +51.24% | Apr 13, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 6, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $30 | Buy | Reiterates | $30 | +81.49% | Mar 10, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $34 | Buy | Maintains | $34 | +105.69% | Mar 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +117.79% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
25.26M
from 16.96M
Increased by 48.92%
Revenue Next Year
34.11M
from 25.26M
Increased by 35.04%
EPS This Year
-2.81
from -2.10
EPS Next Year
-2.08
from -2.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 26.6M | 36.2M | ||||||
| Avg | 25.3M | 34.1M | ||||||
| Low | 23.6M | 31.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 56.8% | 43.2% | ||||||
| Avg | 48.9% | 35.0% | ||||||
| Low | 39.1% | 26.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | -2.22 | -1.47 | |||||
| Avg | -2.81 | -2.08 | |||||
| Low | -3.24 | -2.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.